CF vs REGN · P/E 12, rev $5.94B vs P/E 14, rev $14.34B
CF Industries Holdings Inc (CF) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
CF Industries Holdings Inc (CF) is a agricultural inputs company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CF revenue for 2024-12-31 was $5.94B. Net income was $1.48B. Revenue was down 10.5% from 2023-12-31 to 2024-12-31. CF currently screens at market cap $14.98B and trailing P/E 12.2.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CF currently screens at market cap $14.98B and trailing P/E 12.2. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CF and REGN stock pages for the full models.
Not investment advice.